Users Coming Off Weight-Loss Injections Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that people who stop using new slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional diet and exercise programs.

Research printed in a prominent health publication shows that while overweight individuals can lose a large proportion of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.

"Users using these treatments must be cognizant of the danger of rapid rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery suggests a reversion to original weight within about 18 months.

Analyzing Approaches

The study, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with conventional dieting.

The team point out that individuals who lose weight through lifestyle changes alone generally see a slower creep back—approximately 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Experts propose the mechanism of the jabs explains the accelerated rebound.

These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making binge eating far more likely."

A Lifelong Disease?

Medical guidelines recommend the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, given the significant potential of weight regain, the therapy should be considered life-long.

This opinion is supported by drug manufacturers, who say that the findings "underscore the long-term character of obesity," similar to managing diseases like high blood pressure.

Patient Experiences

Individuals who have come off the jabs explain a intense return of hunger.

"It felt as if a switch flipping and I was suddenly extremely hungry," said an individual.

The struggle is exacerbated if patients have not adopted permanent dietary or behavioural changes during therapy.

Widespread Use

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.

• Use is higher among women compared to men.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, researchers emphasize that while these medications are potent tools for shedding pounds, they are not a permanent cure and maintained weight loss likely depends on combined behavioural changes.